RK

Rachana Korat Solanki

Active Director Designated Partner DIN 10448504
DIN 10448504 First appointment Dec 2023
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Rachana Korat Solanki

Data last updated:

Rachana Korat Solanki is a Designated Partner at Pathogenius Diagnostics Llp (since 2023).

DIN 10448504
Primary Designation Designated Partner
First Appointment 30 Dec 2023
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner30 Dec 20232023Active

Board colleagues of Rachana Korat Solanki

NameDINCompanyDesignation
Ashok Champaklal Mehta00181191Pathogenius Diagnostics LlpDesignated Partner
Parul Ashok Mehta00181526Pathogenius Diagnostics LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Pathogenius Diagnostics Llp
Premium access

Shareholding and investment profile for Rachana Korat Solanki

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rachana Korat Solanki

Rachana Korat Solanki currently holds 1 directorship: Pathogenius Diagnostics Llp (Designated Partner, since 30 Dec 2023).

Rachana Korat Solanki was first appointed on 30 Dec 2023 as Designated Partner at Pathogenius Diagnostics Llp.

The current boards of Rachana Korat Solanki's companies include Ashok Champaklal Mehta (Pathogenius Diagnostics Llp), Parul Ashok Mehta (Pathogenius Diagnostics Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available